The Future of Pulmonary Hypertension Therapy with Stem Cell Treatment in Switzerland
Pulmonary hypertension (PH) is a debilitating disease with limited treatment options. Stem cell therapy offers promising advancements in PH management in Switzerland. This article analyzes the current state and future prospects of stem cell-based therapies for PH, exploring their potential to revolutionize treatment approaches and improve patient outcomes.












